Advances and Challenges of Tissue Vascular Scaffolds and Supercritical Carbon Dioxide Technology in Cardiovascular Diseases

组织血管支架和超临界二氧化碳技术在心血管疾病中的进展与挑战

阅读:1

Abstract

BACKGROUND: Atherosclerosis often leads to ischemic heart disease and peripheral artery disease. Traditional revascularization technique such as bypass grafting using autologous vessels are commonly employed. However, limitations arise when patients lack suitable grafts due to underlying diseases or previous surgeries, prompting the need to substitute vessel grafts. Due to the high biocompatibility of decellularized products (grafts or scaffolds) prepared using supercritical carbon dioxide (ScCO(2)), it has been widely applied in decellularization-related technologies in recent years. Therefore, this review article will comprehensively discuss the current developments in tissue vascular scaffolds applied to the treatment of cardiovascular diseases, with a particular focus on the application of supercritical carbon dioxide technology in this field and the challenges it faces. METHOD: This review was compiled by searching relevant references on PubMed database (before June 2024) based on selected key words and specific terms. RESULTS: ScCO(2) is an effective and eco-friendly extraction agent widely used in industries like food, pharmaceuticals, and cosmetics. It has been applied in decellularization processes to obtain extracellular matrices (ECMs) from tissues. ScCO(2) technology has emerged as a promising method in cardiovascular disease treatment, particularly for developing tissue vascular scaffolds. ScCO(2) effectively removes cellular components while preserving the ECM, ensuring high biocompatibility and reduced immune response. It has been applied to decellularize tissues like heart valves and arteries, creating scaffolds that mimic natural ECM to support cell proliferation and tissue regeneration. Despite challenges such as solubility limitations and cost, ScCO(2) offers advantages like low toxicity and ease of use, making it a valuable tool in advancing regenerative medicine for cardiovascular applications. CONCLUSION: ScCO(2) has the advantages of low cellular toxicity, cost-effectiveness, and ease of manipulation. These characteristics have the potential to lead to significant progress in cardiovascular research on tissue regeneration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。